🇺🇸 FDA
Patent

US 11760790

Neutralizing antibodies to HIV-1 Env and their use

granted A61KA61K2039/505A61P

Quick answer

US patent 11760790 (Neutralizing antibodies to HIV-1 Env and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/505, A61P, A61P31/18